CLAIM CARD
A tension within this outcome class arises from the mixed pattern of statistical results observed in a single trial. While some endpoints reached high statistical significance, others did not, suggesting that the anti-inflammatory effect of telmisartan may be context-dependent or specific to certain biomarkers. The absence of corroborating large-scale human RCTs for this specific outcome class means the evidence remains preliminary, with the boundary conditions for a consistent immunomodulatory effect yet to be fully established.
Evidence grade: exploratory
Contradiction status: none
Publication: edeb045d-18ed-49dc-95b6-57f76783ce2b
Provenance: Derivation Web chain
Citation Support
source_1Solomon 2026source_2Din 2026source_3Li 2025source_4Mei 2025source_5Chung 2024